Due to its proto-oncogenic properties, overexpression of CDC25A has been observed in various malignancies, including Non-Hodgkin Lymphoma and esophageal, gastric, lung, thyroid, head, and neck cancers [38]. The gene discussed is CDC25A; the disease is malignant tumor of neck.